Target intelligence / Profile preview

RNA, U6 small nuclear 726, pseudogene (RNU6-726P)

Target
RNU6-726P
Molecular classification
Other, Pseudogene, Non-coding RNA pseudogene
01

Overview

RNU6-726P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA), which in its functional form is a critical noncoding RNA involved in the spliceosome complex responsible for removing introns from pre-mRNA in the nucleus of eukaryotic cells[3][1]. Pseudogenes such as RNU6-726P arise through genomic duplication or retrotransposition events and typically contain mutations that prevent them from forming functional RNA or protein products[2][5]. While U6 snRNA is highly conserved and essential for catalytic activity in pre-mRNA splicing[1][3], pseudogenes like RNU6-726P are generally considered nonfunctional genetic elements. In rare cases, some pseudogenes may act as regulatory RNAs, but no specific regulatory function or disease link has been established for RNU6-726P[2]. Limitations & Notes: - There is *no evidence that RNU6-726P is a functional gene or therapeutic drug target*. - The presence of hundreds of U6 snRNA pseudogenes in the genome is typical, and they are usually considered "genomic fossils"[5]. - If structured data are needed for a functional target, the canonical gene is **U6 small nuclear RNA (RNU6)**, not its pseudogene variants. - Sources may refer to pseudogenes as part of regulatory networks, but specific information about RNU6-726P itself is lacking[2].

Other names
RNU6-726PRNA, U6 small nuclear 726, pseudogeneU6 snRNA pseudogene
02

Biological functions

None directly; pseudogenes themselves do not perform biological functions but may potentially impact gene expression through regulatory RNA mechanisms in rare cases
03

Disease associations

Other (Pseudogene involvement in disease is possible via regulatory roles, but there is no established disease association for RNU6-726P itself)

Beyond the preview

Go deeper on RNA, U6 small nuclear 726, pseudogene (RNU6-726P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 726, pseudogene (RNU6-726P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call